These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28232640)

  • 41. Contraception choices in women with underlying medical conditions.
    Bonnema RA; McNamara MC; Spencer AL
    Am Fam Physician; 2010 Sep; 82(6):621-8. PubMed ID: 20842989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study.
    Akour A; Bardaweel S; Awwad O; Al-Muhaissen S; Hussein R
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):459-464. PubMed ID: 29300110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception.
    Craig AD; Steinauer J; Kuppermann M; Schmittdiel JA; Dehlendorf C
    Contraception; 2019 Feb; 99(2):104-110. PubMed ID: 30227121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
    Mansour D
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():35-41; discussion 42-3. PubMed ID: 12659405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unplanned pregnancies in Harare, Zimbabwe: what is the contraceptive history and awareness of the mothers?
    Mbizvo MT; Bonduelle MM; Chadzuka S; Lindmark G; Nystrom L
    Cent Afr J Med; 1997 Jul; 43(7):200-5. PubMed ID: 9431754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The shady side of contraception].
    Lesage-desrousseaux E; Delcroix M; Coliche D; Pigache IP
    Contracept Fertil Sex (Paris); 1985 Apr; 13(4):697-700. PubMed ID: 12340146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prebirth psychosocial factors as predictors of consistency in contraceptive use among Taiwanese adolescent mothers at 6 months postpartum.
    Wang RH; Wang HH
    Public Health Nurs; 2005; 22(4):271-9. PubMed ID: 16150008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [How to choose an oral contraceptive in 1984].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paternal Understanding of Menstrual Concerns in Young Women.
    Girling JE; Hawthorne SCJ; Marino JL; Nur Azurah AG; Grover SR; Jayasinghe YL
    J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):459-467. PubMed ID: 29655581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination.
    Egawa-Takata T; Ueda Y; Morimoto A; Yoshino K; Kimura T; Nishikawa N; Sekine M; Horikoshi Y; Takagi T; Enomoto T
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1965-71. PubMed ID: 26420072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of progestational compounds in gynaecology and obstetrics.
    Shah PN
    J Obstet Gynaecol India; 1970 Jun; 20(3):298-315. PubMed ID: 12275252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.
    de Melo NR
    Womens Health (Lond); 2010 Sep; 6(5):721-35. PubMed ID: 21080791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Menstrual pattern and late tubal patency following tubal sterilization.
    Al Tagi AH; Hassanein MK; Saleh AA; Wahab SA; Sakr E; Afifi B; El Agizi HM
    Popul Sci; 1985; 6():111-21. PubMed ID: 12349091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Instructions for combined pill users.
    Reese M; Hatcher RA
    Contracept Technol Update; 1985 Jan; 6(1):19-20. PubMed ID: 12279914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential public sector cost-savings from over-the-counter access to oral contraceptives.
    Foster DG; Biggs MA; Phillips KA; Grindlay K; Grossman D
    Contraception; 2015 May; 91(5):373-9. PubMed ID: 25732570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contraception for midlife women.
    Root WB
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):227-35. PubMed ID: 1596431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.